Breaking News Instant updates and real-time market news.

ITMR

Itamar Medical

$16.27 /

-1.91 (-10.51%)

08:17
06/12/20
06/12
08:17
06/12/20
08:17

Itamar Medical initiated with an Outperform at SVB Leerink

SVB Leerink analyst Richard Newitter initiated coverage of Itamar Medical with an Outperform rating and $30 price target. Newitter says Itamar is an underappreciated high growth story with a unique home sleep apnea test solution that is poised to continue taking share in an expanding HSAT segment. As Itamar extends its distribution capabilities and grows awareness for WatchPAT's value proposition within this growing HSAT category, Newitter projects the company can triple its sales over the next three years driving an above-average 30% CAGR in the process.

ITMR Itamar Medical
$16.27 /

-1.91 (-10.51%)

06/12/20 SVB Leerink
Itamar Medical initiated with an Outperform at SVB Leerink
05/28/20 Alliance Global Partners
Itamar Medical price target raised to $22.75 from $17.75 at Alliance Global
05/27/20 Piper Sandler
Piper Sandler positive on Itamar's tailwinds, salesforce expansion
04/14/20 Alliance Global Partners
Itamar Medical price target lowered to $17.75 from $19.50

TODAY'S FREE FLY STORIES

Hot Stocks
EDAP TMS announces appointment of Ryan Rhodes as CEO of company's subsidiary » 08:15
06/15/21
06/15
08:15
06/15/21
08:15
EDAP

EDAP TMS

$6.78 /

+0.05 (+0.74%)

EDAP TMS announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDAP EDAP TMS
$6.78 /

+0.05 (+0.74%)

EDAP EDAP TMS
$6.78 /

+0.05 (+0.74%)

04/28/21
Fly Intel: Top five analyst initiations
04/28/21 Piper Sandler
EDAP TMS initiated with an Overweight at Piper Sandler
04/01/21 H.C. Wainwright
EDAP TMS price target raised to $12 from $10 at H.C. Wainwright
01/25/21 Lake Street
EDAP TMS initiated with a Buy at Lake Street
EDAP EDAP TMS
$6.78 /

+0.05 (+0.74%)

  • 23
    Apr
EDAP EDAP TMS
$6.78 /

+0.05 (+0.74%)

Conference/Events
Akoya Biosciences management to meet virtually with Piper Sandler » 08:14
06/15/21
06/15
08:14
06/15/21
08:14
AKYA

Akoya Biosciences

$19.61 /

-0.39 (-1.95%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

05/11/21 JPMorgan
Akoya Biosciences initiated with an Overweight at JPMorgan
05/11/21 Morgan Stanley
Morgan Stanley starts Akoya Biosciences at Overweight with $26 price target
05/11/21 Morgan Stanley
Akoya Biosciences initiated with an Overweight at Morgan Stanley
05/11/21 Piper Sandler
Akoya Biosciences initiated with an Overweight at Piper Sandler
AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

  • 16
    Apr
AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

Conference/Events
Akoya Biosciences management to meet virtually with Piper Sandler » 08:14
06/15/21
06/15
08:14
06/15/21
08:14
AKYA

Akoya Biosciences

$19.61 /

-0.39 (-1.95%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

05/11/21 JPMorgan
Akoya Biosciences initiated with an Overweight at JPMorgan
05/11/21 Morgan Stanley
Morgan Stanley starts Akoya Biosciences at Overweight with $26 price target
05/11/21 Morgan Stanley
Akoya Biosciences initiated with an Overweight at Morgan Stanley
05/11/21 Piper Sandler
Akoya Biosciences initiated with an Overweight at Piper Sandler
AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

  • 16
    Apr
AKYA Akoya Biosciences
$19.61 /

-0.39 (-1.95%)

Hot Stocks
OptimizeRx discusses 2021 strategic operating plan » 08:13
06/15/21
06/15
08:13
06/15/21
08:13
OPRX

OptimizeRx

$50.14 /

-0.05 (-0.10%)

OptimizeRx discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OPRX OptimizeRx
$50.14 /

-0.05 (-0.10%)

OPRX OptimizeRx
$50.14 /

-0.05 (-0.10%)

05/07/21 B. Riley
OptimizeRx price target raised to $80 from $75 at B. Riley
04/12/21 RBC Capital
OptimizeRx initiated with an Outperform at RBC Capital
02/25/21 B. Riley Securities
OptimizeRx price target raised to $75 from $60 at B. Riley Securities
02/25/21 Roth Capital
OptimizeRx price target raised to $85 from $70 at Roth Capital
OPRX OptimizeRx
$50.14 /

-0.05 (-0.10%)

  • 09
    Feb
OPRX OptimizeRx
$50.14 /

-0.05 (-0.10%)

Conference/Events
Abiomed management to meet virtually with Piper Sandler » 08:13
06/15/21
06/15
08:13
06/15/21
08:13
ABMD

Abiomed

$302.32 /

+3.13 (+1.05%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABMD Abiomed
$302.32 /

+3.13 (+1.05%)

ABMD Abiomed
$302.32 /

+3.13 (+1.05%)

06/08/21 Piper Sandler
Tweet suggests Abiomed study trending in right direction, says Piper Sandler
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Piper Sandler
Abiomed earnings selloff a buying opportunity, says Piper Sandler
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
ABMD Abiomed
$302.32 /

+3.13 (+1.05%)

ABMD Abiomed
$302.32 /

+3.13 (+1.05%)

Hot Stocks
Apollo Medical appoints Jeremy Jackson as Chief Quality Officer » 08:10
06/15/21
06/15
08:10
06/15/21
08:10
AMEH

Apollo Medical

$48.82 /

+0.41 (+0.85%)

Apollo Medical Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMEH Apollo Medical
$48.82 /

+0.41 (+0.85%)

AMEH Apollo Medical
$48.82 /

+0.41 (+0.85%)

AMEH Apollo Medical
$48.82 /

+0.41 (+0.85%)

Hot Stocks
First American settles with SEC over disclosure controls for $487,616 » 08:10
06/15/21
06/15
08:10
06/15/21
08:10
FAF

First American

$65.59 /

-0.42 (-0.64%)

First American Financial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FAF First American
$65.59 /

-0.42 (-0.64%)

FAF First American
$65.59 /

-0.42 (-0.64%)

05/03/21 Credit Suisse
First American initiated with an Outperform at Credit Suisse
04/15/21 Truist
First American price target raised to $72 from $66 at Truist
02/12/21 Susquehanna
First American price target raised to $67 from $63 at Susquehanna
02/12/21 Barclays
First American price target raised to $73 from $68 at Barclays
FAF First American
$65.59 /

-0.42 (-0.64%)

Hot Stocks
The Real Brokerage Inc. commences trading on Nasdaq » 08:10
06/15/21
06/15
08:10
06/15/21
08:10
REAX

The Real Brokerage Inc.

$9.21 /

+0.21 (+2.33%)

The Real Brokerage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Eyenovia provides update on three Phase 3 programs » 08:10
06/15/21
06/15
08:10
06/15/21
08:10
EYEN

Eyenovia

$5.47 /

+0.03 (+0.55%)

Eyenovia provided a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYEN Eyenovia
$5.47 /

+0.03 (+0.55%)

EYEN Eyenovia
$5.47 /

+0.03 (+0.55%)

04/01/21 H.C. Wainwright
Eyenovia price target raised to $8 from $6 at H.C. Wainwright
03/01/21 Northland
Eyenovia initiated with an Outperform at Northland
12/30/20 H.C. Wainwright
H.C. Wainwright reiterates $6 target on Eyenovia after new drug submission
10/23/20 H.C. Wainwright
Eyenovia price target lowered to $6 from $7 at H.C. Wainwright
EYEN Eyenovia
$5.47 /

+0.03 (+0.55%)

  • 19
    Aug
Hot Stocks
Proterra to trade under PTRA and PTRAW symbols » 08:08
06/15/21
06/15
08:08
06/15/21
08:08
PTRA

Proterra

/

+

, ACTC

ArcLight Clean Transition

$18.08 /

-0.95 (-4.99%)

Proterra (PTRA) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACTC ArcLight Clean Transition
$18.08 /

-0.95 (-4.99%)

ACTC ArcLight Clean Transition
$18.08 /

-0.95 (-4.99%)

ACTC ArcLight Clean Transition
$18.08 /

-0.95 (-4.99%)

Hot Stocks
Aramark announces exclusive partnership with Talon » 08:08
06/15/21
06/15
08:08
06/15/21
08:08
ARMK

Aramark

$37.64 /

-0.365 (-0.96%)

Aramark has secured an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARMK Aramark
$37.64 /

-0.365 (-0.96%)

ARMK Aramark
$37.64 /

-0.365 (-0.96%)

12/08/20 Barclays
Aramark price target raised to $40 from $35 at Barclays
11/18/20 RBC Capital
Aramark price target raised to $31 from $28 at RBC Capital
11/18/20 Barclays
Aramark price target raised to $35 from $25 at Barclays
10/22/20 Citi
Citi downgrades Aramark to Neutral with normalcy still year away
ARMK Aramark
$37.64 /

-0.365 (-0.96%)

ARMK Aramark
$37.64 /

-0.365 (-0.96%)

Hot Stocks
Urban Tea announces name change to Bit Brother Limited » 08:07
06/15/21
06/15
08:07
06/15/21
08:07
BTB

Bit Brother Limited

/

+

, MYT

Urban Tea

$2.29 /

+0.14 (+6.51%)

Urban Tea (MYT), is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MYT Urban Tea
$2.29 /

+0.14 (+6.51%)

Initiation
Concentrix initiated with an Outperform at Barrington » 08:07
06/15/21
06/15
08:07
06/15/21
08:07
CNXC

Concentrix

$152.08 /

-2.09 (-1.36%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNXC Concentrix
$152.08 /

-2.09 (-1.36%)

CNXC Concentrix
$152.08 /

-2.09 (-1.36%)

01/07/21 Cross Research
Concentrix initiated with a Buy at Cross Research
12/08/20 Stifel
Synnex downgraded to Hold from Buy at Stifel
12/07/20 BofA
Concentrix initiated with a Buy at BofA
12/07/20 BofA
Concentrix initiated with a Buy at BofA
CNXC Concentrix
$152.08 /

-2.09 (-1.36%)

CNXC Concentrix
$152.08 /

-2.09 (-1.36%)

Hot Stocks
Enlivex Therapeutics issued European patent for Allocetra » 08:06
06/15/21
06/15
08:06
06/15/21
08:06
ENLV

Enlivex Therapeutics

$9.75 /

+0.12 (+1.25%)

Enlivex Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENLV Enlivex Therapeutics
$9.75 /

+0.12 (+1.25%)

ENLV Enlivex Therapeutics
$9.75 /

+0.12 (+1.25%)

03/02/21 H.C. Wainwright
Enlivex Therapeutics price target raised to $33 from $22 at H.C. Wainwright
  • 10
    Feb
ENLV Enlivex Therapeutics
$9.75 /

+0.12 (+1.25%)

ENLV Enlivex Therapeutics
$9.75 /

+0.12 (+1.25%)

Hot Stocks
Xperi's TiVo signs master services agreement with NCTC » 08:05
06/15/21
06/15
08:05
06/15/21
08:05
XPER

Xperi

$21.79 /

-0.56 (-2.51%)

TiVo, a wholly-owned…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XPER Xperi
$21.79 /

-0.56 (-2.51%)

XPER Xperi
$21.79 /

-0.56 (-2.51%)

02/24/21 B. Riley Securities
Xperi price target raised to $34 from $33 at B. Riley Securities
11/16/20 B. Riley Securities
Xperi shares can nearly double from current levels, says B. Riley Securities
11/10/20 BWS Financial
Xperi settlement paves way for $26 share price, says BWS Financial
09/28/20 BWS Financial
Walmart availability could mean Xperi ready for mass market, says BWS Financial
XPER Xperi
$21.79 /

-0.56 (-2.51%)

XPER Xperi
$21.79 /

-0.56 (-2.51%)

Hot Stocks
OncoCyte enters software collaboration with Echelon Diagnostics » 08:05
06/15/21
06/15
08:05
06/15/21
08:05
OCX

OncoCyte

$5.21 /

-0.245 (-4.50%)

Echelon Diagnostics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCX OncoCyte
$5.21 /

-0.245 (-4.50%)

OCX OncoCyte
$5.21 /

-0.245 (-4.50%)

04/12/21 Lake Street
AACR data strengthens 'pan-cancer credentials' for OncoCyte, says Lake Street
04/12/21 Piper Sandler
OncoCyte remains a top pick small-cap pick at Piper Sandler
03/30/21 Piper Sandler
OncoCyte called 'top small-cap pick' at Piper Sandler
03/17/21
Fly Intel: Top five analyst initiations
OCX OncoCyte
$5.21 /

-0.245 (-4.50%)

  • 05
    Feb
OCX OncoCyte
$5.21 /

-0.245 (-4.50%)

Recommendations
Aethlon Medical price target raised to $11 from $6 at Maxim » 08:04
06/15/21
06/15
08:04
06/15/21
08:04
AEMD

Aethlon Medical

$5.82 /

-0.61 (-9.49%)

Maxim analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AEMD Aethlon Medical
$5.82 /

-0.61 (-9.49%)

AEMD Aethlon Medical
$5.82 /

-0.61 (-9.49%)

06/01/21 H.C. Wainwright
Aethlon Medical initiated with a Buy at H.C. Wainwright
01/08/21
Fly Intel: Top five analyst initiations
01/08/21 Maxim
Aethlon Medical initiated with a Buy at Maxim
AEMD Aethlon Medical
$5.82 /

-0.61 (-9.49%)

Recommendations
New York City REIT price target raised to $13 from $10 at B. Riley » 08:04
06/15/21
06/15
08:04
06/15/21
08:04
NYC

New York City REIT

$13.75 /

+1.83 (+15.35%)

B. Riley analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NYC New York City REIT
$13.75 /

+1.83 (+15.35%)

NYC New York City REIT
$13.75 /

+1.83 (+15.35%)

03/18/21 B. Riley Securities
New York City REIT price target lowered to $10 from $11.50 at B. Riley
10/20/20 B. Riley Securities
New York City REIT initiated with a Neutral at B. Riley Securities
10/20/20 B. Riley Securities
New York City REIT initiated with a Neutral at B. Riley Securities
NYC New York City REIT
$13.75 /

+1.83 (+15.35%)

Recommendations
Global Net Lease price target raised to $24 from $23 at B. Riley » 08:04
06/15/21
06/15
08:04
06/15/21
08:04
GNL

Global Net Lease

$19.98 /

+0.18 (+0.91%)

B. Riley analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GNL Global Net Lease
$19.98 /

+0.18 (+0.91%)

GNL Global Net Lease
$19.98 /

+0.18 (+0.91%)

03/01/21 B. Riley Securities
Global Net Lease price target raised to $23 from $21 at B. Riley Securities
09/22/20 Ladenburg
Ladenburg stays Neutral on Global Net Lease due to growth headwinds
06/30/20 Berenberg
Global Net Lease initiated with a Buy at Berenberg
Hot Stocks
Jounce Therapeutics achieves first milestone in license agreement with Gilead » 08:04
06/15/21
06/15
08:04
06/15/21
08:04
JNCE

Jounce Therapeutics

$6.98 /

-0.07 (-0.99%)

, GILD

Gilead

$68.15 /

+0.09 (+0.13%)

Jounce Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$6.98 /

-0.07 (-0.99%)

GILD Gilead
$68.15 /

+0.09 (+0.13%)

JNCE Jounce Therapeutics
$6.98 /

-0.07 (-0.99%)

04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
12/04/20 H.C. Wainwright
Jounce Therapeutics assumed with a Buy at H.C. Wainwright
GILD Gilead
$68.15 /

+0.09 (+0.13%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
JNCE Jounce Therapeutics
$6.98 /

-0.07 (-0.99%)

GILD Gilead
$68.15 /

+0.09 (+0.13%)

  • 10
    Mar
GILD Gilead
$68.15 /

+0.09 (+0.13%)

JNCE Jounce Therapeutics
$6.98 /

-0.07 (-0.99%)

GILD Gilead
$68.15 /

+0.09 (+0.13%)

GILD Gilead
$68.15 /

+0.09 (+0.13%)

Recommendations
Industrial Logistics Property Trust price target raised to $32 from $29 at B. Riley » 08:03
06/15/21
06/15
08:03
06/15/21
08:03
ILPT

Industrial Logistics Property Trust

$26.46 /

+0.12 (+0.46%)

B. Riley analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILPT Industrial Logistics Property Trust
$26.46 /

+0.12 (+0.46%)

ILPT Industrial Logistics Property Trust
$26.46 /

+0.12 (+0.46%)

04/28/21 B. Riley
Industrial Logistics price target raised to $29 from $28 at B. Riley
04/26/21 BTIG
Industrial Logistics Property Trust initiated with a Neutral at BTIG
04/26/21 BTIG
Industrial Logistics Property Trust initiated with a Neutral at BTIG
07/30/20 B. Riley FBR
Industrial Logistics price target raised to $29 from $27 at B. Riley FBR
ILPT Industrial Logistics Property Trust
$26.46 /

+0.12 (+0.46%)

Hot Stocks
Amyris to acquire OLIKA, terms not disclosed » 08:03
06/15/21
06/15
08:03
06/15/21
08:03
AMRS

Amyris

$15.66 /

-0.175 (-1.11%)

Amyris announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMRS Amyris
$15.66 /

-0.175 (-1.11%)

AMRS Amyris
$15.66 /

-0.175 (-1.11%)

06/01/21 HSBC
Amyris initiated with a Buy at HSBC
03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
AMRS Amyris
$15.66 /

-0.175 (-1.11%)

  • 09
    Apr
AMRS Amyris
$15.66 /

-0.175 (-1.11%)

AMRS Amyris
$15.66 /

-0.175 (-1.11%)

AMRS Amyris
$15.66 /

-0.175 (-1.11%)

Recommendations
Global Medical REIT price target raised to $18 from $16 at B. Riley » 08:03
06/15/21
06/15
08:03
06/15/21
08:03
GMRE

Global Medical REIT

$15.89 /

+0.31 (+1.99%)

B. Riley analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GMRE Global Medical REIT
$15.89 /

+0.31 (+1.99%)

GMRE Global Medical REIT
$15.89 /

+0.31 (+1.99%)

04/16/21 BMO Capital
Global Medical REIT initiated with an Outperform at BMO Capital
03/17/21 Baird
Global Medical REIT risk/reward positive following selloff, says Baird
09/30/20
Fly Intel: Top five analyst initiationsNewPage
09/30/20 Baird
Global Medical REIT assumed with an Outperform at Baird
GMRE Global Medical REIT
$15.89 /

+0.31 (+1.99%)

  • 16
    Mar
Recommendations
Community Healthcare price target raised to $52 from $50 at B. Riley » 08:02
06/15/21
06/15
08:02
06/15/21
08:02
CHCT

Community Healthcare

$51.50 /

+1.005 (+1.99%)

B. Riley analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHCT Community Healthcare
$51.50 /

+1.005 (+1.99%)

CHCT Community Healthcare
$51.50 /

+1.005 (+1.99%)

11/27/20 Truist
Community Healthcare price target raised to $50 from $49 at Truist
11/25/20 Evercore ISI
Community Healthcare upgraded to Outperform from In Line at Evercore ISI
11/05/20 B. Riley Securities
Community Healthcare price target raised to $49 from $47 at B. Riley Securities
09/30/20 Baird
Community Healthcare assumed with an Outperform at Baird
CHCT Community Healthcare
$51.50 /

+1.005 (+1.99%)

Recommendations
Xenia Hotels price target raised to $20 from $18 at B. Riley » 08:02
06/15/21
06/15
08:02
06/15/21
08:02
XHR

Xenia Hotels

$20.35 /

-0.145 (-0.71%)

B. Riley analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XHR Xenia Hotels
$20.35 /

-0.145 (-0.71%)

XHR Xenia Hotels
$20.35 /

-0.145 (-0.71%)

05/25/21 BMO Capital
Xenia Hotels upgraded to Outperform from Market Perform at BMO Capital
03/16/21 BMO Capital
Xenia Hotels price target raised to $22 from $18 at BMO Capital
02/01/21 B. Riley Securities
Xenia Hotels price target raised to $15 from $14 at B. Riley Securities
01/20/21 Morgan Stanley
Xenia Hotels downgraded to Underweight after outperformance at Morgan Stanley
XHR Xenia Hotels
$20.35 /

-0.145 (-0.71%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.